Nervgen Pharma Corp Stock Price on October 10, 2024
| NGENF Stock | USD 1.85 0.06 3.35% |
If you're considering investing in NervGen OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of NervGen Pharma stands at 1.85, as last reported on the 23rd of November, with the highest price reaching 1.94 and the lowest price hitting 1.78 during the day. NervGen Pharma Corp has Sharpe Ratio of -0.0039, which conveys that the firm had a -0.0039% return per unit of risk over the last 3 months. NervGen Pharma exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify NervGen Pharma's insignificant Risk Adjusted Performance, mean deviation of 3.1, and Standard Deviation of 4.64 to check out the risk estimate we provide.
NervGen OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
NervGen |
Sharpe Ratio = -0.0039
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NGENF |
Estimated Market Risk
| 4.66 actual daily | 41 59% of assets are more volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average NervGen Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NervGen Pharma by adding NervGen Pharma to a well-diversified portfolio.
NervGen Pharma Valuation on October 10, 2024
It is possible to determine the worth of NervGen Pharma on a given historical date. On October 10, 2024 NervGen was worth 1.72 at the beginning of the trading date compared to the closed value of 1.69. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of NervGen Pharma otc stock. Still, in general, we apply an absolute valuation method to find NervGen Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of NervGen Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against NervGen Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 1.76 | 1.78 | 1.70 | 1.70 | 22,200 | |
10/10/2024 | 1.72 | 1.72 | 1.64 | 1.69 | 15,634 |
| 1.71 | 1.73 | 1.71 | 1.73 | 1,005 |
| Backtest NervGen Pharma | | | NervGen Pharma History | | | NervGen Pharma Valuation | Previous | Next |
NervGen Pharma Trading Date Momentum on October 10, 2024
| On October 11 2024 NervGen Pharma Corp was traded for 1.73 at the closing time. The highest daily price throughout the period was 1.73 and the lowest price was 1.71 . The daily volume was 1 K. The net trading volume on 10/11/2024 added to the next day price rise. The trading delta at closing time to closing price of the next trading day was 2.37% . The trading delta at closing time to current closing price is 4.14% . |
NervGen Pharma Corp Fundamentals Correlations and Trends
By evaluating NervGen Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among NervGen Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. NervGen financial account trend analysis is a perfect complement when working with valuation or volatility modules.About NervGen Pharma OTC Stock history
NervGen Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NervGen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NervGen Pharma Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NervGen Pharma stock prices may prove useful in developing a viable investing in NervGen Pharma
NervGen Pharma Corp., together with its subsidiaries, engages in the discovery, development, and commercialization of pharmaceutical treatments for medical conditions related to nervous system damage. NervGen Pharma Corp. was incorporated in 2017 and is based in Vancouver, Canada. NERVGEN PHARMA operates under Biotechnology classification in the United States and is traded on OTC Exchange.
NervGen Pharma OTC Stock Technical Analysis
NervGen Pharma technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Price Boundaries
NervGen Pharma Period Price Range
Low | November 23, 2024
| High |
0.00 | 0.00 |
NervGen Pharma Corp cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
NervGen Pharma November 23, 2024 Market Strength
Market strength indicators help investors to evaluate how NervGen Pharma otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NervGen Pharma shares will generate the highest return on investment. By undertsting and applying NervGen Pharma otc stock market strength indicators, traders can identify NervGen Pharma Corp entry and exit signals to maximize returns
NervGen Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for NervGen Pharma's price direction in advance. Along with the technical and fundamental analysis of NervGen OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NervGen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.82) | |||
| Treynor Ratio | (0.12) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for NervGen OTC Stock analysis
When running NervGen Pharma's price analysis, check to measure NervGen Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NervGen Pharma is operating at the current time. Most of NervGen Pharma's value examination focuses on studying past and present price action to predict the probability of NervGen Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NervGen Pharma's price. Additionally, you may evaluate how the addition of NervGen Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |